Ocythera Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 2

Ocythera General Information

Description

Developer of selective and non-retinoid small molecule inhibitors designed to modulate local retinoic acid signaling for the treatment of rare bone diseases. The company offers therapies that target specific enzymes in the retinoic acid metabolism pathway, enabling clients to access safer and effective treatments that avoid the systemic toxicity of conventional retinoids for patients with rare bone disorders like Hereditary Multiple Osteochondromas and Fibrodysplasia Ossificans Progressiva.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Montreal, Quebec
  • Canada
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Drug Delivery
Drug Discovery
Vertical(s)
Corporate Office
  • Montreal, Quebec
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ocythera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 27-Jan-2026 Completed Generating Revenue
To view Ocythera’s complete valuation and funding history, request access »

Ocythera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ocythera Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
adMare Bioinnovations Corporation Minority
Investissement Quebec PE/Buyout Minority
To view Ocythera’s complete investors history, request access »

Ocythera FAQs

  • When was Ocythera founded?

    Ocythera was founded in 2024.

  • Where is Ocythera headquartered?

    Ocythera is headquartered in Montreal, Canada.

  • What is the size of Ocythera?

    Ocythera has 3 total employees.

  • What industry is Ocythera in?

    Ocythera’s primary industry is Biotechnology.

  • Is Ocythera a private or public company?

    Ocythera is a Private company.

  • What is Ocythera’s current revenue?

    The current revenue for Ocythera is .

  • Who are Ocythera’s investors?

    adMare Bioinnovations and Investissement Quebec have invested in Ocythera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process